Matrix metalloproteinase-9 delays wound healing in a murine wound model

Surgery

Volumn 147, Issue 2, 2010, Pages 295-302

  Reiss, Matthew J ^a   Han, Yan Ping ^a   Garcia, Edwin ^a   Goldberg, Mytien ^a   Yu, Hong ^a   Garner, Warren L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPHENYLMERCURIC ACETATE; COLLAGEN TYPE 4; GELATINASE B; RECOMBINANT ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; C57BL MOUSE; CELL ADHESION; CELL IMMORTALIZATION; CELL MIGRATION; CHRONIC WOUND; CONTROLLED STUDY; CULTURE MEDIUM; DENSITOMETRY; DISEASE MODEL; ENZYME ACTIVATION; ENZYME PURIFICATION; EPIDERMIS; EPITHELIZATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LENTIVIRINAE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; PUNCH BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

ANIMALS; BASEMENT MEMBRANE; BLOTTING, WESTERN; CELL MOVEMENT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME PRECURSORS; EPITHELIUM; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SKIN; WOUND HEALING;

EID: 74149092281     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.10.016     Document Type: Article

References (16)

1. Vaalamo M., Weckroth M., Puolakkainen P., Kere J., Saarinen P., Lauharanta J., et al. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 135 (1996) 52-59
2. Weckroth M., Vaheri A., Lauharanta J., Sorsa T., and Konttinen Y.T. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 106 (1996) 1119-1124
3. Wysocki A.B., Staiano-Coico L., and Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101 (1993) 64-68
4. Yager D.R., Zhang L.Y., Liang H.X., Diegelmann R.F., and Cohen I.K. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 107 (1996) 743-748
5. Trengove N.J., Langton S.R., and Stacey M.C. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 4 (1996) 234-239
6. Young P.K., and Grinnell F. Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J Invest Dermatol 103 (1994) 660-664
7. Daniels J.T., Geerling G., Alexander R.A., Murphy G., Khaw P.T., and Saarialho-Kere U. Temporal and spatial expression of matrix metalloproteinases during wound healing of human corneal tissue. Exp Eye Res 77 (2003) 653-664
8. Trengove N.J., Stacey M.C., MacAuley S., Bennett N., Gibson J., Burslem F., et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7 (1999) 442-452
9. Reinhardt R.A., Lee H.M., Schmid M., Payne J.B., and Golub L. Relationship between gelatinases and bone turnover in the healing bone defect. J Oral Maxillofac Surg 63 (2005) 1455-1460
10. Galiano R.D., Michaels J., Dobryansky M., Levine J.P., and Gurtner G.C. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 12 (2004) 485-492
11. Han Y.P., Yan C., and Garner W.L. Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin. J Invest Dermatol 128 (2008) 2334-2342
12. Han Y.P., Tuan T.L., Hughes M., Wu H., and Garner W.L. Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem 276 (2001) 22341-22350
13. Han Y.P., Nien Y.D., and Garner W.L. Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J Biol Chem 277 (2002) 27319-27327
14. Colnot D.R., Roos J.C., de Bree R., Wilhelm A.J., Kummer J.A., Hanft G., et al. Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 52 (2003) 576-582
15. Ulrich D., Lichtenegger F., Unglaub F., Smeets R., and Pallua N. Effect of chronic wound exudates and MMP-2/-9 inhibitor on angiogenesis in vitro. Plast Reconstr Surg 116 (2005) 539-545
16. Lindsey M.L., Escobar G.P., Dobrucki L.W., Goshorn D.K., Bouges S., Mingoia J.T., et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol 290 (2006) H232-H239